✦ LIBER ✦

Bone Disease From Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma: Pathogenesis, Interventions, and Future Opportunities

✍ Scribed by Alex R. Minter; Haley Simpson; Brendan M. Weiss; Ola Landgren

Book ID: 117822215
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 756 KB
Volume: 48
Category: Article
ISSN: 1532-8686
DOI: 10.1053/j.seminhematol.2010.11.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pathogenesis of Monoclonal Gammopathy of

Pathogenesis of Monoclonal Gammopathy of Undetermined Significance and Progression to Multiple Myeloma

✍ Adriana Zingone; W. Michael Kuehl 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 528 KB

Role of MicroRNAs From Monoclonal Gammop

Role of MicroRNAs From Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

✍ Katherine R. Calvo; Ola Landgren; Aldo M. Roccaro; Irene M. Ghobrial 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Monoclonal gammopathy of undetermined si

Monoclonal gammopathy of undetermined significance: to screen or not to screen for multiple myeloma?

✍ Ronald S. Go 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Prior Autoimmune Disease and Risk of Mon

Prior Autoimmune Disease and Risk of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma: A Systematic Review

✍ McShane, C. M.; Murray, L. J.; Landgren, O.; O'Rorke, M. A.; Korde, N.; Kunzmann 📂 Article 📅 2014 🏛 American Association for Cancer Research 🌐 English ⚖ 413 KB

Monoclonal gammopathy of undetermined si

Monoclonal gammopathy of undetermined significance: to screen or not to screen for multiple myeloma? – response

✍ Jenny Bird; Judith Behrens; Mark T. Drayson; Ingemar Turesson; Jan Westin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

Monoclonal gammopathy of undetermined si

Monoclonal gammopathy of undetermined significance and multiple myeloma are associated with an increased incidence of venothromboembolic disease

✍ Gordan Srkalovic; Marte G. Cameron; Lisa Rybicki; Steven R. Deitcher; Kandice Ka 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB

## Background: Venous thromboembolic disease (vtd) is a recently recognized complication of thalidomide in combination therapy for patients with multiple myeloma (mm). the authors assessed the frequency of vtd and its risk factors in 612 consecutive patients with plasma cell dyscrasia (pcd) who wer